Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM vs RISPERIDONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISDIPLAM vs RISPERIDONE: Safety Overview

Metric RISDIPLAM RISPERIDONE
Total FAERS Reports 3,619 79,288
Deaths Reported 336 4,120
Death Rate 9.3% 5.2%
Hospitalizations 719 18,771
Average Patient Age 21.8 yrs 31.9 yrs
% Female Patients 55.2% 15.6%
FDA Approval Date Aug 7, 2020 Apr 12, 2007
Manufacturer Genentech, Inc. NuCare Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription